The THC Gummy Problem: Impairment Doesn't Wait for the High to Kick In

A cannabis gummy does not act like a joint. That distinction sits at the center of a body of driving-simulator research now feeding into news coverage of THC edibles and impaired driving, and it's the reason edibles deserve their own evidence base rather than borrowing findings from studies of smoked or vaped cannabis.

The clearest data point comes from a randomized, double-blind, placebo-controlled crossover trial published in 2024 that put people in a driving simulator after they consumed cannabis edibles at different doses. Researchers measured lateral control, essentially how much a driver weaves within a lane, and found impairment rose with dose. The notable detail: weaving showed up even at blood THC concentrations below the per-se legal limits several states use to define impaired driving, with peak levels in the medium- and high-dose groups measured at 1.6 to 3.4 nanograms per milliliter.

That gap between measured blood THC and measured driving performance is a known problem in cannabis pharmacology, not a fluke of one study. There is no level of THC in blood above which everyone is impaired and below which no one is impaired, unlike blood alcohol concentration, which tracks impairment fairly consistently across people. Six states have adopted per-se THC limits of 2 or 5 nanograms per milliliter anyway, and twelve more use zero-tolerance laws. Because regular cannabis users can carry residual THC in their blood long after any impairment has worn off, one study found 43% of regular users exceeded zero-tolerance thresholds even after 48 hours of abstinence, and 5.3% still exceeded the 5 ng/mL mark at that point.

Edibles complicate enforcement further because of how they're absorbed. Smoked or vaped THC reaches the brain within minutes, but an edible has to pass through the digestive system and liver first, a process that takes 30 minutes to two hours before effects begin and that produces 11-hydroxy-THC, a metabolite more potent than the THC inhaled cannabis delivers. Once it starts, the high can last four to twelve hours, far longer than smoking. Colorado's Department of Transportation has run public campaigns specifically warning about this lag, on the theory that people who don't feel high 20 minutes after eating a gummy may decide it's safe to drive, or take a second dose, only to become impaired once they're already behind the wheel.

Roadside enforcement tools haven't caught up to any of this. A randomized trial published in JAMA Psychiatry found that officers using standard field sobriety tests misclassified nearly half of participants who had taken a placebo, not THC, as impaired, a specificity problem that cuts against relying on those tests for cannabis cases specifically. No validated roadside breathalyzer for THC exists yet; a Department of Justice-funded prototype using a 3D-printed breath-detection device made news this year out of Virginia Commonwealth University, but it remains experimental and hasn't been adopted by any jurisdiction's legal framework.

Crash statistics add a layer of uncertainty rather than resolving it. The Insurance Institute for Highway Safety found that legalizing retail cannabis sales was associated with a 6% increase in injury crash rates across five states, alongside a smaller, not statistically significant rise in fatal crashes. Separately, a 2025 analysis found that 41.9% of drivers who died in crashes had active THC in their blood, averaging 30.7 nanograms per milliliter, but that rate held steady over six years and didn't shift after recreational legalization took effect, which makes it hard to draw a direct causal line from legal edibles to that death toll.

None of this argues that edibles are harmless behind the wheel; the dose-response finding in the 2024 simulator study argues the opposite. It argues that the specific risk edibles pose is less about a number on a blood test and more about timing: a THC gummy that hasn't kicked in yet, and a driver who has no reliable way to know that.